Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
USA 88 , 87258729 (1991)
life expectancy would increase by nearly 7 years (1)
Both TRIUMPH-4 and the initial TRANSCEND readouts tested 9 mg and 12 mg only
Eli Lilly (NYSE: LLY) saw its shares climb 5% this past week after announcing that its history-making oral obesity candidate, orforglipron aced the Phase III ATTAIN-2 trial (NCT05872620), which assessed the small molecule glucagon-like peptide-1 (GLP-1) receptor agonist in adults who were obese or overweight and had type 2 diabetes
Its like theyre having a skincare party, and your face is the guest of honour
US$ 26.70
US$ 22.09
US$ 29.54
US$ 28.91
US$ 21.93
US$ 24.36
US$ 25.80
